Conversion Labs, Inc., an Internet-based direct response marketing company, licenses, acquires, creates, and sells various products to consumers worldwide. Its products include Shapiro MD, a shampoo, conditioner, and leave-in foamer for thicker fuller hair; iNR Wellness MD, a nutritional supplement for immune support; and PDF Simpli, a PDF conversion software. The company sells its products through technology infrastructure and relationships with agencies, third party marketers, and online advertising platforms, as well as through its Websites inrwellness.com and shapiromd.com. The company was formerly known as Immudyne, Inc. and changed its name to Conversion Labs, Inc. in June 2018. Conversion Labs, Inc. was incorporated in 1987 and is based in New York, New York.
Industry, Sector and Symbol
Industry Miscellaneous manufacturing industries
Sub-IndustryN/A
SectorRetail/Wholesale
CIKN/A
Phone866-351-5907
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$8.32 million
Profitability
Miscellaneous
Employees16
Next Earnings Date4/3/2020 (Estimated)
OptionableNot Optionable
Conversion Labs (OTCMKTS:CVLB) Frequently Asked Questions
What is Conversion Labs' stock symbol?
Conversion Labs trades on the OTCMKTS under the ticker symbol "CVLB."
When is Conversion Labs' next earnings date?
Has Conversion Labs been receiving favorable news coverage?
News articles about CVLB stock have trended somewhat positive this week, according to InfoTrie. InfoTrie identifies negative and positive press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Conversion Labs earned a media sentiment score of 1.6 on InfoTrie's scale. They also gave media stories about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the stock's share price in the immediate future. View News Stories for Conversion Labs.
Who are some of Conversion Labs' key competitors?
What other stocks do shareholders of Conversion Labs own?
Who are Conversion Labs' key executives?
Conversion Labs' management team includes the folowing people:
- Mr. Justin Schreiber, CEO, Pres & Director (Age 36)
- Mr. Stefan Galluppi, COO, Chief Technology Officer & Director (Age 32)
- Dr. Joseph V. DiTrolio, Chief Medical Officer of North America & Director (Age 68)
- Mr. Robert Kalkstein, Advisor to the CEO (Age 37)
- Mr. Sean Fitzpatrick, Chief Acquisition Officer (Age 36)
How do I buy shares of Conversion Labs?
Shares of CVLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Conversion Labs' stock price today?
One share of CVLB stock can currently be purchased for approximately $0.14.
How big of a company is Conversion Labs?
What is Conversion Labs' official website?
How can I contact Conversion Labs?
Conversion Labs' mailing address is 800 THIRD AVENUE SUITE 2800, NEW YORK NY, 10022. The company can be reached via phone at 866-351-5907 or via email at ir.conversionlabs.com.
MarketBeat Community Rating for Conversion Labs (OTCMKTS CVLB)
| Community Ranking: | | 2.4 out of 5 ( ) |
| Outperform Votes: | | 111 (Thanks for Voting!) |
| Underperform Votes: | | 117 (Thanks for Voting!) |
| Total Votes: | | 228 |
